NICE fast-tracks approval of new skin cancer treatment
Patients in England to be first in Europe to access immunotherapy to stall cancer progressRelated items from OnMedicaStudy shows huge global variation in cancer drug costsMeeting cancer promises and more – a new model for NHS diagnostics?Ten year hormonal therapy cuts breast cancer relapse Cancer treatment good but aftercare less soPut case for adding leukaemia drug to Cancer Drugs Fund, NICE tells company
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Immunotherapy | Leukemia | National Institute for Health and Clinical Excelle | Skin | Skin Cancer | UK Health